discovery :: hegemony :: prophecy :: conspiracy :: eschatology :: anthropology :: cosmology :: philosophy :: epistemology :: teleology  [?]

Tuesday, August 12, 2003

GENETIC WARFARE

Israel developing biological weapons targeting Arabs

Israel has abstained from commenting on reports leaked to Western media that it had developed 'ethnic' biological weapons which target Arabs and exclude Jews, a British daily reported.
Apart from the condemnation of Israeli Knesset Member Dedi Zucker, for processing this weapon which he described as 'immoral,' the Israeli governmental source kept silent toward these information which were attributed to Israeli military sources and Western intelligence.
In its Sunday issue, the British daily 'Sunday Times' said that Israel is embarking on developing biological weapons which can affect people according to their ethnic affiliation.

Arabic News also reports that Israeli chemical tests killed 4 and wounded 25. Tests carried out by an Israeli secret laboratory recently killed four persons and other 25 have been reported wounded in Neis Zayouna district near Tel Aviv, an Israeli daily reported.
The Israeli daily Maariv said on Wednesday that the incident at this laboratory, considered the basis of the Israeli program for biological and chemical weapons, was about to force the Israeli authorities to evacuate the population of Neis Zayouna area estimated are 25,000 unless the laboratory experts claims that risks have been eliminated. Israel flatly denied the report.

In October 1997, Dr. Wayne Nathanson, chief of the Science and Ethics Department of the Medical Society of the United Kingdom, warned the annual meeting of the Society that "gene therapy" might possibly be turned into "gene weapons" which could potentially be used to target particular genes possessed by certain groups of people. These weapons, Nathanson warned, could be delivered not only in the forms already seen in warfare such as gas and aerosol, but could also be added to water supplies, causing not only death but sterility and birth defects in targeted groups.

No comments: